HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paraganglioma and pancreatic neuroendocrine tumor with rare metastatic sites detected on 68Ga-DOTATATE PET/CT imaging.

Abstract
Pancreatic neuroendocrine tumors (PNETs) represent a small percentage of all pancreatic malignancies, and most of these present as metastatic disease. Somatostatin receptor scintigraphy had been used successfully for the assessment of patients with NET. Somatostatin receptor scintigraphy is indispensable for localization of ectopic NET and the distribution of NET throughout the body.
AuthorsRahul Vithalrao Parghane, Bhagwant Rai Mittal, Jaya Shukla, Pranab Dey, Anish Bhattacharya, Rakesh Kochhar
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 40 Issue 3 Pg. 256-7 (Mar 2015) ISSN: 1536-0229 [Electronic] United States
PMID25546216 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Organometallic Compounds
  • Radiopharmaceuticals
  • gallium Ga 68 dotatate
Topics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Neoplasm Metastasis (diagnostic imaging)
  • Organometallic Compounds
  • Pancreatic Neoplasms (diagnostic imaging)
  • Paraganglioma (diagnostic imaging)
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: